Carmustina Teva

Carmustine Teva is a chemotherapy drug used to treat certain types of cancer. It is administered intravenously and is manufactured by Teva B.V. in the EU.

Carmustine Teva is primarily used in the treatment of brain tumors, including glioblastoma multiforme and other malignant gliomas. It may also be used in combination with other chemotherapy drugs for certain types of cancer. The drug works by interfering with the growth of cancer cells, helping to slow or stop their spread.

Common effects of Carmustine Teva may include nausea, vomiting, and fatigue. Some patients may experience hair loss, fever, or changes in blood cell counts. These effects can vary in severity and duration, depending on the individual and their treatment plan.

Carmustine Teva should be handled with care, as it is a potent chemotherapy drug. It is important to follow the instructions provided by a healthcare professional when administering this medication. Patients should be monitored regularly for any signs of adverse reactions.

Carmustine Teva may interact with other medications, including those that affect the immune system or blood cell production. It is important to inform a healthcare professional about all medications being taken to avoid potential interactions. Alcohol and certain foods may also affect the efficacy of the drug.